178448-14-1

Basic information

• Product Name: 4-Chloro-2-Methyl-5-nitrobenzonitrile
• Synonyms: 4-Chloro-2-Methyl-5-nitrobenzonitrile
• CAS NO: 178448-14-1
• Molecular Formula: C₈H₅ClN₂O₂
• Molecular Weight: 196.5905
• Mol File: 178448-14-1.mol

Chemical Properties

• Boiling Point: 320.0±42.0 °C(Predicted)
• Appearance: /
• Density: 1.41±0.1 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• CAS DataBase Reference: 4-Chloro-2-Methyl-5-nitrobenzonitrile(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Chloro-2-Methyl-5-nitrobenzonitrile(178448-14-1)
• EPA Substance Registry System: 4-Chloro-2-Methyl-5-nitrobenzonitrile(178448-14-1)

Safety Data

• Hazardous Substances Data: 178448-14-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
4-Chloro-2-Methyl-5-nitrobenzonitrile is used as an intermediate in the synthesis of various pharmaceutical compounds. Its unique structure and functional groups make it a valuable building block for the development of new drugs and medicinal agents.
Used in Chemical Research:
4-Chloro-2-Methyl-5-nitrobenzonitrile is utilized in chemical research for studying the properties and reactions of substituted benzonitriles. It can provide insights into the reactivity and stability of different functional groups and their influence on the overall chemical behavior of the compound.
Used in Material Science:
4-Chloro-2-Methyl-5-nitrobenzonitrile can be employed in the development of new materials with specific properties, such as high thermal stability or unique optical characteristics. Its structural features can contribute to the design and synthesis of advanced materials for various applications.
Used in Environmental Monitoring:
4-Chloro-2-Methyl-5-nitrobenzonitrile can be used as a reference compound in environmental monitoring studies. Its detection and analysis can help in understanding the presence and distribution of similar hazardous compounds in the environment, contributing to the development of effective remediation strategies.

Upstream product

• 50712-68-0 4-chloro-2-methylbenzonitrile 
• 34648-99-2 4-chloro-2-methyl-5-nitroaniline 

Downstream Products

• 1173434-90-6 5-amino-4-chloro-2-methylbenzonitrile 
• 186666-77-3 7-Methyl-3-oxo-1,2,3,4-tetrahydro-quinoxaline-6-carbonitrile 
• 186666-75-1 N-(4-cyano-5-methyl-2-nitrophenyl)glycine 
• 476660-41-0 4-chloro-2-methyl-5-nitrobenzoic acid 

Relevant articles and documents

HETEROCYCLIC COMPOUNDS AS INHIBITORS OF RAS AND METHODS OF USE THEREOF

Compounds having activity as inhibitors of G12C mutant KRAS protein are provided. The compounds have the following structure (I): or a pharmaceutically acceptable salt, stereoisomer or prodrug thereof, wherein A, B, R", Q, W, X, Y, Z, n1, n2and '--" are as defined herein. Methods associated with preparation and use of such compounds, pharmaceutical compositions comprising such compounds and methods to modulate the activity of G12C mutant KRAS protein for treatment of disorders, such as cancer, are also disclosed.

In vitro intrinsic clearance-based optimization of N3- phenylpyrazinones as corticotropin-releasing factor-1 (CRF1) receptor antagonists

A series of pyrazinone-based heterocycles was identified as potent and orally active corticotropinreleasing factor-1 (CRF1) receptor antagonists. Selected compounds proved efficacious in an anxiety model in rats; however, pharmacokinetic proper

Use of EP4 receptor ligands in the treatment of IL-6 involved diseases

Methods of treating IL-6 involved diseases with EP4 receptor ligands, including EP4 receptor antagonists. Assays to determine the effect of test compounds on PGE2-induced whole blood cells activation.

Structure-activity relationships of alkyl- and alkoxy-substituted 1,4- dihydroquinoxaline-2,3-diones: Potent and systemically active antagonists for the glycine site of the NMDA receptor

We report on a series of alkyl- and alkoxy-substituted 1,4- dihydroquinoxaline-2,3-diones (QXs), prepared as a continuation of our structure-activity relationship (SAR) study of QXs as antagonists for the glycine site of the N-methyl-D-aspartate (NMDA) re